AbbVie

Today, we announced topline results from the Phase 2 trial evaluating an investigational antibody-drug conjugate (#ADC) in heavily pre-treated patients with folate receptor-alpha positive, platinum-sensitive #OvarianCancer (PSOC). Learn more: https://bit.ly/3RhbwYa [Video description: On-screen text reads, “Oncology News.”]

Our medicines can be a source of hope for patients. That’s why our #MarketAccess teams work every day to ensure the patients who need them can access them. Explore our #career opportunities to help make a remarkable impact: https://bit.ly/4aTAL9T

Creating tomorrow’s cures requires investing in today’s #entrepreneurs. That’s why AbbVie Ventures was established 15 years ago and has been investing in novel, transformational #therapeutics at discovery and preclinical stages ever since. Learn more in the 2023 Year-In-Review: https://lnkd.in/gKc5yctT [Image description: Two scientists talking while working in lab. On-screen text reads, "Investing to Develop Tomorrow’s Cures by Today’s Entrepreneurs. 2023 Year-In-Review."]

At tomorrow’s Social Innovation Summit, Claudia Carravetta, our VP of corporate responsibility and president of the AbbVie Foundation, will be speaking with MATTER's Steven Collens about our collective effort to advance #HealthEquity through innovative solutions. Learn more about the summit and see the full agenda: https://bit.ly/3R6VAb5 #SIS24

#IBD is a complex set of diseases, meaning patients have diverse needs. Through ongoing research and development, we’re working to find solutions to help them manage their disease. Read how: https://bit.ly/3x01p3b #UlcerativeColitis #Crohns [Image description: Sofie Berg, Pharm.D., Ph.D., Therapeutic Area Head, International Immunology, International Medical Affairs, AbbVie, says, “We are motivated to bring new treatment options to patients in need through our commitment to ongoing research and development in gastroenterology.”]

Conferences and meetings like #ASCO24 are a great opportunity to network, connect with #recruiters and discuss your career goals. Hear two of our senior recruiters share a few tips on how to prepare ahead of attending a large meeting and learn more about our #career opportunities: https://bit.ly/4aJZZrw [Video description: Two recruiters attending a meeting and putting on event badges, setting up, sharing advice and waving with colleagues.]

At #ASCO24, we’ll be presenting data from Phase 1 studies of #ADCs in patients with advanced solid tumors, and in patients with advanced colorectal #cancer. Learn about our differentiated approach to developing solid tumor research: https://bit.ly/3VmBpsc

To welcome #PrideMonth, we asked members of our PRIDE employee resource group (ERG) to share some of their intersecting identities and what supporting the #LGBTQ+ community means to them. Learn how this ERG fosters an inclusive space for our employees year-round: https://bit.ly/3R8ZyQh #BelongAtAbbVie [Video description: AbbVie employees sharing their identities, orientation, participation in and/or support of the LGBTQ+ community to celebrate Pride Month.]

At #ASCO24, our #oncology team will be onsite showcasing our expanding solid tumor research and commitment to transforming cancer care. Stop by booth 23093 to learn more.

NEWS: The European Medicines Agency's #CHMP granted a positive opinion for our investigational treatment in #UlcerativeColitis. Read more: https://bit.ly/4bDSiUJ #IBD [Video description: On-screen text reads, “Immunology News. Positive CHMP Opinion in Ulcerative Colitis.”]